GE HealthCare Technologies (GEHC) Stock Forecast & Price Target

GE HealthCare Technologies
Bull Case

Here are some ways that investors could benefit from investing in GE HealthCare Technologies Inc.:

• GE HealthCare Technologies Inc. recently demonstrated strong fundamental performance by beating analyst expectations in its latest quarterly report, posting earnings per share of $1.13 against a consensus estimate of $1.04, while also exceeding revenue forecasts with $5.29 billion in sales, indicating robust demand for its diagnostic imaging and patient care solutions.
• The company has secured significant regulatory and market expansion opportunities, most notably winning the CE Mark for its Photonova Spectra photon-counting CT technology, which allows GE HealthCare Technologies Inc. to expand its international reach into European markets and other CE-regulated regions, potentially driving future revenue growth.
• There is a notable discrepancy between the current stock price of $68.86 and the average analyst price target of $77.73, suggesting that the stock may be undervalued relative to Wall Street's consensus view, which currently holds a "Hold" rating with several analysts issuing "Outperform" recommendations.
• Insider confidence appears high, as key executives including CEO Peter J. Arduini and CFO James Saccaro made significant personal purchases of GE HealthCare Technologies Inc. stock in late April and early May 2026, signaling that company leadership believes the current valuation offers an attractive entry point.
• The company maintains a conservative financial profile with a low beta of 0.70, which means GE HealthCare Technologies Inc. is less volatile than the broader market, and it continues to return capital to shareholders through a consistent quarterly dividend, providing a stable income stream for investors.